Gene: CDK14
Official Full Name: cyclin dependent kinase 14provided by HGNC
Gene Summary: Enables cyclin binding activity and cyclin-dependent protein serine/threonine kinase activity. Involved in G2/M transition of mitotic cell cycle and regulation of canonical Wnt signaling pathway. Located in cytosol; nucleoplasm; and plasma membrane. Part of cytoplasmic cyclin-dependent protein kinase holoenzyme complex. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO36115 | CDK14 Knockout cell line (HeLa) | Human | CDK14 | 1:3~1:6 | Negative | Online Inquiry |
KO36116 | CDK14 Knockout cell line (HCT 116) | Human | CDK14 | 1:2~1:4 | Negative | Online Inquiry |
KO36117 | CDK14 Knockout cell line (HEK293) | Human | CDK14 | 1:3~1:6 | Negative | Online Inquiry |
CDK14 Gene Knockout Cell Lines are highly specialized cellular models that have undergone the precise inhibition of the cyclin-dependent kinase 14 (CDK14) gene, which plays a vital role in the regulation of gene expression and cell cycle progression. These knockout cell lines are engineered to facilitate in-depth studies of CDK14’s functions, mechanisms of action, and its implications in various biological processes, particularly in cancer biology and cellular differentiation.
The key function of CDK14 is its involvement in the regulation of the transcription of specific genes through phosphorylation of the RNA polymerase II C-terminal domain. By knocking out CDK14, researchers can elucidate the downstream signaling pathways and cellular responses that depend on this kinase, thus providing insights into its role in tumorigenesis, as CDK14 has been implicated in various malignancies.
The scientific importance of these cell lines extends to both research and clinical applications. In research laboratories, they serve as critical tools for understanding the genetic and molecular underpinnings of diseases associated with CDK14 dysregulation. In clinical settings, they can aid in the identification of potential therapeutic targets and strategies for cancer treatment, making them invaluable in drug discovery and development phases.
Compared to alternative models, CDK14 Gene Knockout Cell Lines offer the unique advantage of being precisely engineered to not only eliminate the gene of interest but also maintain the physiological context of cellular function. This ensures more reliable and reproducible results, enhancing the predictive value of experimental findings compared to traditional methods such as transient gene knockdown approaches.
For researchers and clinicians focused on elucidating the complexities of cellular signaling and therapeutic advancements, CDK14 Gene Knockout Cell Lines provide a powerful and versatile platform. Our company, with its commitment to cutting-edge genetic engineering and comprehensive understanding of cellular biology, delivers high-quality products that empower the scientific community to drive innovation and discovery in biological research.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.